19717850

Source:http://linkedlifedata.com/resource/pubmed/id/19717850

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0004238, umls-concept:C0008976, umls-concept:C0965129, umls-concept:C1274040, umls-concept:C1280500, umls-concept:C1549485, umls-concept:C2745955
pubmed:issue	19
pubmed:dateCreated	2009-10-2
pubmed:databankReference	http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00336336
pubmed:abstractText	This ancillary analysis of the GISSI-HF database aims at assessing the effect of rosuvastatin on the occurrence of atrial fibrillation (AF) in patients with chronic heart failure (HF) who were not in AF at study entry.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19717850-19717849
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8006263
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-Arrhythmia Agents, http://linkedlifedata.com/resource/pubmed/chemical/Fatty Acids, Omega-3, http://linkedlifedata.com/resource/pubmed/chemical/Fluorobenzenes, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA..., http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines, http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides, http://linkedlifedata.com/resource/pubmed/chemical/rosuvastatin
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1522-9645
pubmed:author	pubmed-author:CosmiFrancoF, pubmed-author:FabbriGiannaG, pubmed-author:FranzosiMaria GraziaMG, pubmed-author:GISSI-HF Investigators, pubmed-author:LatiniRobertoR, pubmed-author:LucciDonataD, pubmed-author:MaggioniAldo PAP, pubmed-author:MarchioliRobertoR, pubmed-author:NicolosiGian LuigiGL, pubmed-author:PorcuMaurizioM, pubmed-author:StefanelliSeveroS, pubmed-author:TavazziLuigiL, pubmed-author:TognoniGianniG
pubmed:issnType	Electronic
pubmed:volume	30
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2327-36
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:19717850-Aged, pubmed-meshheading:19717850-Anti-Arrhythmia Agents, pubmed-meshheading:19717850-Atrial Fibrillation, pubmed-meshheading:19717850-Chronic Disease, pubmed-meshheading:19717850-Double-Blind Method, pubmed-meshheading:19717850-Drug Therapy, Combination, pubmed-meshheading:19717850-Fatty Acids, Omega-3, pubmed-meshheading:19717850-Female, pubmed-meshheading:19717850-Fluorobenzenes, pubmed-meshheading:19717850-Heart Failure, pubmed-meshheading:19717850-Humans, pubmed-meshheading:19717850-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:19717850-Kaplan-Meier Estimate, pubmed-meshheading:19717850-Male, pubmed-meshheading:19717850-Middle Aged, pubmed-meshheading:19717850-Pyrimidines, pubmed-meshheading:19717850-Risk Factors, pubmed-meshheading:19717850-Sulfonamides, pubmed-meshheading:19717850-Treatment Outcome
pubmed:year	2009
pubmed:articleTitle	Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial.
pubmed:affiliation	GISSI-HF Coordinating Center, ANMCO Research Center, Via La Marmora, 34, 50121 Florence, Italy. maggioni@anmco.it
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study